World Wrestling Entertainment, Inc., an integrated media and entertainment company, engages in the sports entertainment business in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.

Along with watching the kung fu movies on Sat. it was all about watching wrestling on TV as well.  My era of wrestlers didn’t involve WWE superstar, John Cena, and his signature “you can’t see me” hand gesture.  Nor did I ever see Dwayne “The Rock” Johnson wrestle.  The only screen I ever see Dwayne on are the moving screen.  My era involved André the Giant and Hulk Hogan.  The rivalry that had is perhaps is one of the most important in professional wrestling history.

Andre the Giant’s real name was André René Roussimoff who also happen to be a French actor as well.  But his wrestling name was so fitting.  By the time Andre was 12, he was already 6 foot 3 and 240 lbs and later grew to 7 foot 4 and 540 lbs.

Terry Gene Bollea aka Hulk Hogan, was the Man.  He was the face of the WWE back then and is one the most popular professional wrestlers of all-time. However, I never got the pleasure to play his video game, Hulk Hogan’s Main Event.

Then I grew up and found out the WWE doesn’t exist to really entertain us, it’s about making money.  If you had held the stock in the last five years, well you would be up about 400% with EPS growth of 45% per year the last three years.  But if you still hold the stock, well you would be down about 30% since April.  The decline in the stock in recent months is largely due to declines in their viewership.  For example, SmackDown TV ratings declined 13% in the first quarter 2019 and the average attendance at WWE’s live events across North America fell 4% in June.

However, with the company’s third-quarter earnings report less than a week away, analysts remain bullish on WWE’s longer-term outlook.

Morgan Stanley Weighs In

On Wednesday, Morgan Stanley analyst Benjamin Swinburne reiterated his Overweight rating and $85 price target for WWE.

Swinburne said WWE has simply been struggling to meet high expectations in the past two quarters, but he said little has changed about the company’s fundamental outlook.

“Expectations aside, WWE continues to offer exposure to an asset with unique IP, rapidly growing revenues and FCF, and now at its lowest multiple since late ’17,” he wrote in a note.

Morgan Stanley is forecasting high single-digit EBITDA growth for WWE through 2025, and Swinburne said the 2019 sell-off is a buying opportunity.

Source

And the Smart Money is taking notice because today I noticed bullish buying in the January $75 call options where they bought over 6,000 contracts.

At the moment, the momentum is to the downside, but limit. With three months before these contracts expire, there is plenty of time for momentum to reverse…and the catalyst could be when WWE announces earnings next week.

This post is my personal opinion. I’m not a financial advisor, this isn’t financial advise. Do your own research before making investment decisions.

Beyond Meat priced its initial public offering at $25 and skyrocket 800% in less than four months. Beyond Meat, a maker of plant-based meat controls about 10% of the plant based meat market.  And because they have achieved “first to market” they are the new IT THING on Wall Street.  But there valuation is beyond ridiculous.   Their valuation is higher than roughly 25% of the companies in the S&P 500 index and their “first to market” competitive advantage expired.

Kellogg (K) introduced “Incogmeato” and their plant-based burger patties, Chik’n tenders, and Chik’n nuggets which go on sale in early 2020.  Hormel Foods announced its plant-based meat substitute called “Happy Little Plants” is available at select retailers.  The Impossible Foods launched the Impossible Burger through Burger King in August.  Kroger said they will sell a new line of branded plant-based burgers, other meatless products like dips, pasta sauces and cookie dough in the coming months under their Simple Truth Plant Based label.

Beyond Meat Inc. was initiated at sell with a $120 price target at CFRA, with analyst Arun Sundaram saying the plant-based meat company will be overtaken by bigger players entering the space.

“We think larger packaged food companies will end up as the category leaders in the space given their vast global footprint and embedded relationships throughout the supply chain,” Sundaram wrote in a note. “Yet we expect Beyond Meat to be the greatest disrupter in this space since no public packaged food peer comes close to Beyond Meat in terms of research and development spend as a percentage of sales.”

Sundaram notes that “many think Impossible Foods’ Impossible Burger tastes better than the Beyond Burger.”

Source

The call is a bit late and should have been made when the chart was suggesting that price was going lower.

But now we are just $10 from that $100 level I talked about one month ago.

The $100 level represents price at a discount.  But, don’t listen to me, just pay attention to what the Smart Money is doing.

Heading into the third quarter of 2019, a total of 16 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 16 from one quarter earlier.

With a general bullishness amongst the heavyweights, some big names have jumped into Beyond Meat, Inc. (NASDAQ:BYND) headfirst. Citadel Investment Group, managed by Ken Griffin, created the most valuable call position in Beyond Meat, Inc. (NASDAQ:BYND). Citadel Investment Group had $117.8 million invested in the company at the end of the quarter. OZ Management also initiated a $11.9 million position during the quarter. The other funds with brand new BYND positions are Brad Farber’s Atika Capital, Robert Henry Lynch’s Aristeia Capital, and Anthony Bozza’s Lakewood Capital Management.

Source

I personally envision the $100 level will be an accumulation level for the Smart Money.  I think price will hang out near the $100 level for a bit, until the Smart Money is able to fill all their buy orders and then I think price will move higher.

Prediction…Beyond Meat Goes Down To $100 First Before Up To $200

Prediction…Beyond Meat Goes Down To $100 First Before Up To $200 – Part 2

This post is my personal opinion. I’m not a financial advisor, this isn’t financial advise. Do your own research before making investment decisions.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon’s natural hand movements outside the body into corresponding micro-movements inside the patient’s body.

Intuitive Surgical, Inc. has been at the forefront of robot-assisted surgery for more than two decades. The beauty of their products is they allow quicker recovery times for patients undergoing surgery through minimally-invasive surgery which lower the bill for all parties involved.

Traditional open surgery involves a large cut so the surgeon can see the part of the bodying being worked on.  Minimally invasive surgery involves small cuts and accessories like small tools, cameras, and lights that fit through several tiny cuts in your skin.  And minimally invasive surgeries done by robotic technology allows for more precise control through an operative field in 3-D resulting in a speedier recovery spent at home vs. in the hospital. 

Robotic surgery is steadily carving its niche across a wide array of surgical fields within MedTech. In neurosurgery, image-guided robots enable the examination of brain lesions without resulting in any major damage to adjacent tissues.   In orthopedics, robotic surgery helps shape the femur to precisely fit prosthetic hip-joint replacements. Currently, an increasing number of orthopedic surgeons are opting for robot-assisted surgery for knee, hip and spine.  Robot-assisted surgery has also been finding its application in urology, especially in prostatectomy. Complex gynecological surgeries have also been witnessing the increasing adoption of robotics, using the Da Vinci Surgical System.

Source

It’s no wonder that over
the last five years, Intuitive Surgical earnings per share have grown 21% per
year, which has translated for their stock price increasing 28% per year during
that same time frame.  And this past
week, their earning results continue to impress.

Intuitive Surgical
reported earnings per share of $3.43 a share in the third quarter, beating
expectations of $2.96.  Revenue also
topped expectations at $1,128 million, compared to $921 million in the third
quarter of 2018.

The company credited the earnings beat due to increased U.S. general surgery and worldwide urologic procedures utilizing their da Vinci robot.

275 da Vinci robot were shipped in the quarter, an increase of 19% vs. the year-earlier period.  There are now there were 5,406 installed da Vinci systems worldwide and this number will only increase as the cost of health care continues to rise.

Source

Speaking of rising, where is the stock heading next, let go to the charts to find out? Right now the playing field is between the weekly demand at $450 and the weekly supply at $580.

Thus, the chart suggests to go short if price makes it up to the daily supply at $580.

This post is my personal opinion. I’m not a financial advisor, this isn’t financial advise. Do your own research before making investment decisions.